Schroder Asia Pacific annual report reveals revenue increase
Schroder Asia Pacific unveiled a significant increase in revenue in its annual report Tuesday.
Schroder Asia Pacific unveiled a significant increase in revenue in its annual report Tuesday.
The equities investor announced £4.91m net revenue after tax for the year ended September 30th, a sizeable jump from the £4.03m reported in the previous year.
The company's gearing rose from 4.4% at the beginning of the year to 5.7% by year's end.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The net asset value of the company recorded a total return of 28.7% over the year, exceeding the benchmark of the MSCI All Countries Asia ex Japan Index which rose 15.7% over the same period.
"Regional markets made positive progress over the year under review despite some challenging global developments, particularly the continued bouts of uncertainty over the future of the euro with the focus shifting from the smaller economies of Greece and Portugal to the systemically more critical cases of Spain and Italy," the company said in a statement.
"The relative performance of the company's portfolio has been strong over the period. The main contributors were strong stock selection in Korea, Hong Kong, Taiwan and Singapore, with lesser added value from the Philippines, Thailand and Indonesia."
The results come off the back of the appointment of Rosemary Morgan as Non-Executive Director of the company in July. Morgan worked as a Japanese equity fund manager for 16 years at John Govett before joining the Institutional Client team at Fidelity, and RBS from mid 2007.
Schroder Asia Pacific was given the authority to purchase up to 14.99% of its issued shared capital for cancellation at the last annual general meeting in February 2012. However no ordinary shares were acquired by directors for the year ended September 30th.
Shares remained unchanged at 249.00p at 13:25 Tuesday.
Shareholders have been urged to attend the next annual general meeting on January 29th 2013 where a presentation will be held on prospects for Asia and the company's investment strategy.
RD
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
What the Employment Rights Bill means for your job
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published